- Home
- CVR vs CLDI Comparison
CVR vs CLDI Comparison
Compare CVR & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- CLDI
- Stock Information
- Founded
- CVR 1920
- CLDI 2014
- Country
- CVR United States
- CLDI United States
- Employees
- CVR N/A
- CLDI N/A
- Industry
- CVR Industrial Machinery/Components
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVR Industrials
- CLDI Health Care
- Exchange
- CVR Nasdaq
- CLDI Nasdaq
- Market Cap
- CVR 11.1M
- CLDI 10.2M
- IPO Year
- CVR N/A
- CLDI N/A
- Fundamental
- Price
- CVR $12.12
- CLDI $0.56
- Analyst Decision
- CVR
- CLDI
- Analyst Count
- CVR 0
- CLDI 0
- Target Price
- CVR N/A
- CLDI N/A
- AVG Volume (30 Days)
- CVR 4.2K
- CLDI 41.6M
- Earning Date
- CVR 08-12-2025
- CLDI 08-12-2025
- Dividend Yield
- CVR 0.99%
- CLDI N/A
- EPS Growth
- CVR N/A
- CLDI N/A
- EPS
- CVR N/A
- CLDI N/A
- Revenue
- CVR $26,379,081.00
- CLDI N/A
- Revenue This Year
- CVR N/A
- CLDI N/A
- Revenue Next Year
- CVR N/A
- CLDI N/A
- P/E Ratio
- CVR N/A
- CLDI N/A
- Revenue Growth
- CVR N/A
- CLDI N/A
- 52 Week Low
- CVR $8.15
- CLDI $0.20
- 52 Week High
- CVR $22.27
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- CVR 46.01
- CLDI 65.65
- Support Level
- CVR $12.04
- CLDI $0.23
- Resistance Level
- CVR $12.49
- CLDI $1.60
- Average True Range (ATR)
- CVR 0.57
- CLDI 0.15
- MACD
- CVR -0.06
- CLDI 0.07
- Stochastic Oscillator
- CVR 30.00
- CLDI 36.55
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.